Synergistic anti-SARS-CoV-2 activity of repurposed anti-parasitic drug combinations

Overview of attention for article published in BMC Pharmacology and Toxicology, June 2022

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#15 of 492)
High Attention Score compared to outputs of the same age (94th percentile)
High Attention Score compared to outputs of the same age and source (92nd percentile)

So far, Altmetric has seen 89 X posts from 70 X users, with an upper bound of 208,444 followers.

@YUKI_nantoka @nozakitakehide ニクロサミド、イベルメクチン、クロロキンの組み合わせのin vitro抗SARS-CoV-2活性は、Vero E6および肺上皮細胞Calu-3で評価された。 https://t.co/okdZ8O27mV

RT @TigerGyroscope: 「転用された抗寄生虫薬併用による相乗的な抗SARS-COV-2活性」タイ・マヒドン大学医学部シリラート病院の研究。結果：「（Vero E6細胞に対して）ニクロサミド＋イベルメクチンは99%以上の最高阻害レベルを達成し」「最高の相乗…

@DrSusanOliver1 @MutualAwareLtd You showed a preprint, here's a published study showing ivm worked in human airway cells at quite low doses. https://t.co/4PYX2W5djj What say you?

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 85 additional X posts.